Literature DB >> 27451451

Longitudinal Investigation of Carriage Rates, Counts, and Genotypes of Toxigenic Clostridium difficile in Early Infancy.

Hiroyuki Kubota1, Hiroshi Makino2, Agata Gawad3, Akira Kushiro4, Eiji Ishikawa2, Takafumi Sakai2, Takuya Akiyama2, Kazunori Matsuda2, Rocio Martin5, Jan Knol6, Kenji Oishi2.   

Abstract

UNLABELLED: Asymptomatic infant carriers of toxigenic Clostridium difficile are suggested to play a role in the transmission of C. difficile infection (CDI) in adults. However, the mode of C. difficile carriage in infants remains to be fully elucidated. We investigated longitudinal changes in carriage rates, counts, and strain types of toxigenic C. difficile in infants. Stools collected from 111 healthy infants in Belgium periodically from birth until the age of 6 months were examined by quantitative PCR targeting 16S rRNA and toxin genes. Toxigenic C. difficile was detected in 18 of 111 infants (16%) in the period up to the age of 6 months. The carriage rate of toxigenic C. difficile remained below 5% until the age of 3 months. The carriage rate increased to 13% 1 week after weaning (average age, 143 days) and reached 16% at the age of 6 months. Counts of toxigenic C. difficile bacteria ranged from 10(4) to 10(8) cells/g of stool. Notably, two infants retained >10(8) cells/g of stool for at least several weeks. Average counts in the 18 infants hovered around 10(7) cells/g of stool from the age of 3 days until the age of 6 months, showing no age-related trend. Genotyping of toxigenic C. difficile isolates from the 18 infants revealed that 11 infants each retained a particular monophyletic strain for at least a month. The genotype most frequently identified was the same as that frequently identified in symptomatic adult CDI patients. Thus, toxigenic C. difficile strains-potential causes of CDI in adults-colonized the infants' intestines. IMPORTANCE: Our study provides longitudinal data on counts and strain types of toxigenic C. difficile in infants. We found that considerable numbers of toxigenic C. difficile bacteria colonized the infants' intestines. The results of strain typing suggest that toxigenic C. difficile carried by healthy infants could be potentially pathogenic to adults. These results and findings are informative not only for ecological studies but also for efforts to prevent or control the spread of CDI in adults.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27451451      PMCID: PMC5038049          DOI: 10.1128/AEM.01540-16

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  40 in total

1.  Factors influencing the composition of the intestinal microbiota in early infancy.

Authors:  John Penders; Carel Thijs; Cornelis Vink; Foekje F Stelma; Bianca Snijders; Ischa Kummeling; Piet A van den Brandt; Ellen E Stobberingh
Journal:  Pediatrics       Date:  2006-08       Impact factor: 7.124

2.  Host and pathogen factors for Clostridium difficile infection and colonization.

Authors:  Vivian G Loo; Anne-Marie Bourgault; Louise Poirier; François Lamothe; Sophie Michaud; Nathalie Turgeon; Baldwin Toye; Axelle Beaudoin; Eric H Frost; Rodica Gilca; Paul Brassard; Nandini Dendukuri; Claire Béliveau; Matthew Oughton; Ivan Brukner; Andre Dascal
Journal:  N Engl J Med       Date:  2011-11-03       Impact factor: 91.245

Review 3.  Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life.

Authors:  Sushrut Jangi; J Thomas Lamont
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-07       Impact factor: 2.839

4.  Clostridium difficile carriage in healthy infants in the community: a potential reservoir for pathogenic strains.

Authors:  Clotilde Rousseau; Isabelle Poilane; Loic De Pontual; Anne-Claire Maherault; Alban Le Monnier; Anne Collignon
Journal:  Clin Infect Dis       Date:  2012-07-25       Impact factor: 9.079

5.  Recurrent infection with epidemic Clostridium difficile in a peripartum woman whose infant was asymptomatically colonized with the same strain.

Authors:  Michelle T Hecker; Michelle M Riggs; Claudia K Hoyen; Christina Lancioni; Curtis J Donskey
Journal:  Clin Infect Dis       Date:  2008-03-15       Impact factor: 9.079

6.  [Clostridium difficile and diarrhea in infants in the first half-year of life].

Authors:  R S Cherkasskaia; N Dzhamali; M Marina; N V Makarova; G A Samsygina; N A Semina; T P Komarovskaia
Journal:  Pediatriia       Date:  1992

7.  Epidemiology of Clostridium difficile in infants.

Authors:  H E Larson; F E Barclay; P Honour; I D Hill
Journal:  J Infect Dis       Date:  1982-12       Impact factor: 5.226

8.  A clinical risk index for Clostridium difficile infection in hospitalised patients receiving broad-spectrum antibiotics.

Authors:  K W Garey; T K Dao-Tran; Z D Jiang; M P Price; L O Gentry; H L Dupont
Journal:  J Hosp Infect       Date:  2008-08-23       Impact factor: 3.926

9.  Growth inhibition of Clostridium difficile by intestinal flora of infant faeces in continuous flow culture.

Authors:  T Yamamoto-Osaki; S Kamiya; S Sawamura; M Kai; A Ozawa
Journal:  J Med Microbiol       Date:  1994-03       Impact factor: 2.472

10.  Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.

Authors:  Charlie G Buffie; Vanni Bucci; Richard R Stein; Peter T McKenney; Lilan Ling; Asia Gobourne; Daniel No; Hui Liu; Melissa Kinnebrew; Agnes Viale; Eric Littmann; Marcel R M van den Brink; Robert R Jenq; Ying Taur; Chris Sander; Justin R Cross; Nora C Toussaint; Joao B Xavier; Eric G Pamer
Journal:  Nature       Date:  2014-10-22       Impact factor: 49.962

View more
  7 in total

Review 1.  Hospital Infection Control: Clostridioides difficile.

Authors:  Nicholas A Turner; Deverick J Anderson
Journal:  Clin Colon Rectal Surg       Date:  2020-02-25

2.  Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.

Authors:  Zev H Davidovics; Sonia Michail; Maribeth R Nicholson; Larry K Kociolek; Nikhil Pai; Richard Hansen; Tobias Schwerd; Aldo Maspons; Raanan Shamir; Hania Szajewska; Nikhil Thapar; Tim de Meij; Alexis Mosca; Yvan Vandenplas; Stacy A Kahn; Richard Kellermayer
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-01       Impact factor: 2.839

3.  Caloric restriction disrupts the microbiota and colonization resistance.

Authors:  Reiner Jumpertz von Schwartzenberg; Jordan E Bisanz; Svetlana Lyalina; Peter Spanogiannopoulos; Qi Yan Ang; Jingwei Cai; Sophia Dickmann; Marie Friedrich; Su-Yang Liu; Stephanie L Collins; Danielle Ingebrigtsen; Steve Miller; Jessie A Turnbaugh; Andrew D Patterson; Katherine S Pollard; Knut Mai; Joachim Spranger; Peter J Turnbaugh
Journal:  Nature       Date:  2021-06-23       Impact factor: 69.504

4.  High prevalence of toxigenic Clostridium difficile in public space lawns in Western Australia.

Authors:  Peter Moono; Su Chen Lim; Thomas V Riley
Journal:  Sci Rep       Date:  2017-02-01       Impact factor: 4.379

5.  Long-term colonization exceeding six years from early infancy of Bifidobacterium longum subsp. longum in human gut.

Authors:  Kaihei Oki; Takuya Akiyama; Kazunori Matsuda; Agata Gawad; Hiroshi Makino; Eiji Ishikawa; Kenji Oishi; Akira Kushiro; Junji Fujimoto
Journal:  BMC Microbiol       Date:  2018-12-12       Impact factor: 3.605

6.  Modelling diverse sources of Clostridium difficile in the community: importance of animals, infants and asymptomatic carriers.

Authors:  A McLure; A C A Clements; M Kirk; K Glass
Journal:  Epidemiol Infect       Date:  2019-01       Impact factor: 2.451

7.  Some simple rules for estimating reproduction numbers in the presence of reservoir exposure or imported cases.

Authors:  Angus McLure; Kathryn Glass
Journal:  Theor Popul Biol       Date:  2020-04-15       Impact factor: 1.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.